ARTICLE | Clinical News
Inovio preclinical data
December 17, 2012 8:00 AM UTC
In mice, Inovio's SynCon DNA CMV vaccine delivered with the company's electroporation system induced "strong and broad" CD8+ and CD4+ T cell responses. The product is a synthetic DNA vaccine targeting...